RecruitingNCT00669266
Adrenal Tumors - Pathogenesis and Therapy
Investigation of the Tumorigenesis of Adrenal Tumors and Evaluation of New Therapeutic Options - Untersuchungen Zur Tumorgenese Von Nebennierentumoren Und Evaluation Neuer Therapieoptionen
Sponsor
University of Wuerzburg
Enrollment
500 participants
Start Date
Sep 1, 2002
Study Type
OBSERVATIONAL
Conditions
Summary
The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.
Eligibility
Max Age: 100 Years
Inclusion Criteria1
- adrenal tumor detected by imaging
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00669266
Related Trials
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT041190243 locations
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
NCT001072891 location
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
NCT032060601 location
Familial Investigations of Childhood Cancer Predisposition
NCT030502681 location
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
NCT060663337 locations